Clinical trialNCT02991274CompletedObservational

ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory

SponsorAstraZenecaEnrollment897Locally Advanced or Metastatic EGFR(+) NSCLC Patients

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Caicun Zhou
Shanghai Pulmonary Hospital, Shanghai, China
Principal Investigator
clinicaltrials.gov ↗
Jie He
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator
clinicaltrials.gov ↗
Jie Wang
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Research Site
Beijing, China
Research Site
Beijing, China
Research Site
Changchun, China
Research Site
Changchun, China
Research Site
Chengdu, China
Research Site
Guangzhou, China
Research Site
Hangzhou, China
Research Site
Hangzhou, China
Research Site
Hangzhou, China
Research Site
Hangzhou, China
Research Site
Harbin, China
Research Site
Hefei, China
Research Site
Hohhot, China
Research Site
Jinan, China
Research Site
Kunming, China
Research Site
Linhai, China
Research Site
Nanchang, China
Research Site
Nanjing, China
Research Site
Qingdao, China
Research Site
Shanghai, China
Research Site
Shanghai, China
Research Site
Shenyang, China
Research Site
Shenzhen, China
Research Site
Wuhan, China
Research Site
Wuhan, China
Research Site
Xi'an, China
Research Site
Xi'an, China
Research Site
Yantai, China
Research Site
Zhengzhou, China
Research Site
Ürümqi, China
Research Site
Ürümqi, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 16 Jan 2017
Primary completion: 29 Jun 2018
Completion: 29 Jun 2018
Last update posted: 12 Jun 2019
Registered enrollment: 897
Registry id: NCT02991274

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.